United States Settles Civil Claims Against Kentucky Pharmacy
LOUISVILLE, Ky. – David J. Hale, United States Attorney for the Western District of Kentucky, today announced the settlement of civil claims by the United States in the amount of $75,000 against
The United States alleges between June 10, 2009, and June 9, 2011, Mayfair Pharmacy could not account for the whereabouts of various hydrocodone products. An accountability audit by the Drug Enforcement Administration (DEA) revealed a shortage of nearly 140,000 hydrocodone tablets. The DEA inspection concluded that Mayfair was in violation of the Uniform Controlled Substances Act for, among other things, the following conduct: failure to maintain records of controlled substances received or dispensed; failure to maintain paper prescriptions of controlled substances in Schedules III through V; failure to notify the DEA of thefts; failure to prevent further diversion by not providing effective
The DEA issued notice of immediate suspension of Mayfair Pharmacy’s Certificate of Registration on August 29, 2011, finding that Mayfair Pharmacy constituted an imminent danger to the public health and safety. A hearing on the immediate suspension was scheduled to take place on October 18,
According to the Owensboro, Kentucky, Police Department and the Louisville, Kentucky, Metro
The settlement amount shall be paid by electronic funds transfer no later than February 10, 2012.
This settlement agreement is neither an admission of liability by Mayfair Pharmacy, Inc., nor a concession by the United States that its claims are not well founded.This case was prosecuted by Assistant United States Attorney Benjamin S. Schecter of the Western District of Kentucky, and was investigated by the DEA and the Owensboro, Kentucky Police Department.